Willingness to Pay for Complete Symptom Relief of Gastroesophageal Reflux Disease | Zendy

Leah Kleinman | Zendy; Emma McIntosh | Zendy; Mandy Ryan | Zendy; Jordana K. Schmier | Zendy; Joseph A. Crawley | Zendy; G. Richard Locke | Zendy; Gregory de Lissovoy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Willingness to Pay for Complete Symptom Relief of Gastroesophageal Reflux Disease

Author(s) -

Leah Kleinman,

Emma McIntosh,

Mandy Ryan,

Jordana K. Schmier,

Joseph A. Crawley,

G. Richard Locke,

Gregory de Lissovoy

Publication year - 2002

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.162.12.1361

Subject(s) - gerd , formulary , medicine , willingness to pay , medical prescription , reflux , disease , family medicine , quality of life (healthcare) , cross sectional study , pediatrics , nursing , pathology , economics , microeconomics

Over $6 billion per year is spent on prescription medication for gastroesophageal reflux disease (GERD). This study is an economic analysis of patients' willingness to pay for a prescription medication that offers complete relief of GERD symptoms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research